U.S. Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases

American Federal health agencies call for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination, officials briefed on the decision said.